Your browser doesn't support javascript.
loading
Genetic diversity of HLA system in two populations from Chiapas, Mexico: Tuxtla Gutiérrez and rural Chiapas.
Barquera, Rodrigo; Juárez-Nicolás, Francisco; Martínez-Álvarez, Julio César; Ponnandai-Shanmugavel, Komathi Sree; Hernández-Zaragoza, Diana Iraíz; Vázquez-Castillo, Tannya Verónica; Arrieta-Bolaños, Esteban; Clayton, Stephen; Solís-Martínez, Raúl; Ortega-Yáñez, Andrea; Arrazola-García, María Araceli; Immel, Alexander; Bravo-Acevedo, Alicia; Vega-Martínez, María Del Rosario; Benítez-Arvizu, Gamaliel; García-Álvarez, Raquel; Martínez-Bezies, Virginia; Escutia-González, Ariadna; Juárez-Barreto, Vicencio; Salgado-Galicia, Norma; Novelo-Garza, Bárbara; Zúñiga, Joaquín; Yunis, Edmond J; Bekker-Méndez, Carolina; Granados, Julio.
Afiliação
  • Barquera R; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany; Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico. Electronic address: http://www.shh.mpg.de/en.
  • Juárez-Nicolás F; Molecular Immunogenetics Laboratory, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
  • Martínez-Álvarez JC; HLA Laboratory, Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Ponnandai-Shanmugavel KS; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany.
  • Hernández-Zaragoza DI; Molecular Genetics Laboratory, Escuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico; Immunogenetics Unit, Técnicas Genéticas Aplicadas a la Clínica (TGAC), Mexico City, Mexico.
  • Vázquez-Castillo TV; Department of Molecular Biology, Laboratorios Diagnóstica, Villahermosa, Tabasco, Mexico.
  • Arrieta-Bolaños E; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany.
  • Clayton S; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany.
  • Solís-Martínez R; Department of Molecular Biology, Laboratorios Diagnóstica, Villahermosa, Tabasco, Mexico.
  • Ortega-Yáñez A; Department of Developmental Genetics and Molecular Physiology, Instituto de Biotecnología (IBT), Universidad Nacional Autónoma de México (UNAM), Cuernavaca, Morelos, Mexico.
  • Arrazola-García MA; HLA Laboratory, Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Immel A; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany; Institute of Clinical Molecular Biology (IKMB), Kiel University, University Hospital, Schleswig-Holstein, Germany.
  • Bravo-Acevedo A; Blood Bank, UMAE Hospital de Gineco Obstetricia, No. 4 "Luis Castelazo Ayala", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Vega-Martínez MDR; Molecular Biology and Histocompatibility Laboratory, Hospital Central Sur de Alta Especialidad, Petróleos Mexicanos (PEMEX), Mexico City, Mexico.
  • Benítez-Arvizu G; Central Blood Bank, Hospital de Especialidades, Unidad Médica de Alta Especialidad (UMAE) Centro Médico Nacional "Siglo XXI", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • García-Álvarez R; Pharmacology Laboratory, Research Unit, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
  • Martínez-Bezies V; Qualth Medical System Laboratory, Mexico City, Mexico.
  • Escutia-González A; Molecular Immunogenetics Laboratory, Instituto Nacional de Pediatría (INP), Mexico City, Mexico.
  • Juárez-Barreto V; Blood Bank, Hospital Infantil de México "Federico Gómez", Mexico City, Mexico.
  • Salgado-Galicia N; Molecular Biology and Histocompatibility Laboratory, Hospital Central Sur de Alta Especialidad, Petróleos Mexicanos (PEMEX), Mexico City, Mexico.
  • Novelo-Garza B; Medical Infrastructure Planning Committee, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Zúñiga J; Laboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico; Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.
  • Yunis EJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: http://www.dana-farber.org.
  • Bekker-Méndez C; Immunology and Infectology Research Unit, Infectology Hospital, Centro Médico Nacional "La Raza", Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Granados J; Department of Transplantation, Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" (INCMNSZ), Mexico City, Mexico.
Hum Immunol ; 81(9): 563-565, 2020 Sep.
Article em En | MEDLINE | ID: mdl-31345692
ABSTRACT
We studied HLA class I (HLA-A, -B) and class II (HLA-DRB1, -DQB1) alleles by PCR-SSP based typing in 173 Mexicans from the state of Chiapas living in the city of Tuxtla Gutiérrez (N = 52) and rural communities (N = 121), to obtain information regarding allelic and haplotypic frequencies. We found that the most frequent haplotypes in Chiapas include 12 Native American and one European haplotype. Admixture estimates revealed that the main genetic components in Chiapas are Native American (71.61 ±â€¯0.58% by ML; 53.16% of Native American haplotypes) and European (26.39 ±â€¯5.05% by ML; 25.86% of European haplotypes), and a less prominent African genetic component (2.00 ±â€¯5.20% by ML; 9.77% of African haplotypes).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Etnicidade / Genética Populacional / Antígenos HLA Limite: Humans País/Região como assunto: Mexico Idioma: En Revista: Hum Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Variação Genética / Etnicidade / Genética Populacional / Antígenos HLA Limite: Humans País/Região como assunto: Mexico Idioma: En Revista: Hum Immunol Ano de publicação: 2020 Tipo de documento: Article
...